核心观点：公司披露24H1 业绩公告，收入同比略降，利润稳健增长。24H1 收入49.8 亿元，同比-2.7%，主要受两年医保结算差影响，叠加23H1 基数较高所致。公司积极降本增效，药品及耗材占收入比同比下降0.6ppt，抵减了两年医保结算差额的影响。24H1 归母净利润为4.34 亿元，同比+9.1%。拟中期派息人民币5 分/股。医院业务收入同比略降，门诊及住院人次均实现增长，次均收入降低。...
Source Link核心观点：公司披露24H1 业绩公告，收入同比略降，利润稳健增长。24H1 收入49.8 亿元，同比-2.7%，主要受两年医保结算差影响，叠加23H1 基数较高所致。公司积极降本增效，药品及耗材占收入比同比下降0.6ppt，抵减了两年医保结算差额的影响。24H1 归母净利润为4.34 亿元，同比+9.1%。拟中期派息人民币5 分/股。医院业务收入同比略降，门诊及住院人次均实现增长，次均收入降低。...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.